- Home
- FTFT vs SLXN Comparison
FTFT vs SLXN Comparison
Compare FTFT & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- SLXN
- Stock Information
- Founded
- FTFT N/A
- SLXN 2008
- Country
- FTFT United States
- SLXN Israel
- Employees
- FTFT N/A
- SLXN N/A
- Industry
- FTFT Business Services
- SLXN
- Sector
- FTFT Consumer Discretionary
- SLXN
- Exchange
- FTFT Nasdaq
- SLXN NYSE
- Market Cap
- FTFT 3.9M
- SLXN 4.3M
- IPO Year
- FTFT N/A
- SLXN N/A
- Fundamental
- Price
- FTFT $0.14
- SLXN $0.99
- Analyst Decision
- FTFT
- SLXN Strong Buy
- Analyst Count
- FTFT 0
- SLXN 1
- Target Price
- FTFT N/A
- SLXN $5.00
- AVG Volume (30 Days)
- FTFT 638.3K
- SLXN 952.7K
- Earning Date
- FTFT 05-19-2025
- SLXN 05-21-2025
- Dividend Yield
- FTFT N/A
- SLXN N/A
- EPS Growth
- FTFT N/A
- SLXN N/A
- EPS
- FTFT N/A
- SLXN N/A
- Revenue
- FTFT $18,543,659.00
- SLXN N/A
- Revenue This Year
- FTFT N/A
- SLXN N/A
- Revenue Next Year
- FTFT N/A
- SLXN N/A
- P/E Ratio
- FTFT N/A
- SLXN N/A
- Revenue Growth
- FTFT N/A
- SLXN N/A
- 52 Week Low
- FTFT $0.13
- SLXN $0.21
- 52 Week High
- FTFT $0.95
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- FTFT 22.77
- SLXN N/A
- Support Level
- FTFT $0.18
- SLXN N/A
- Resistance Level
- FTFT $0.25
- SLXN N/A
- Average True Range (ATR)
- FTFT 0.02
- SLXN 0.00
- MACD
- FTFT -0.00
- SLXN 0.00
- Stochastic Oscillator
- FTFT 8.85
- SLXN 0.00
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.